Denosumab for the treatment of osteoporosis
Denosumab, a specific inhibitor of RANK ligand, is a novel therapy for postmenopausal osteoporosis and related disorders. An extensive clinical development program has evaluated the clinical efficacy and safety of denosumab with several thousand patients being followed for up to 10 years. Combined w...
| मुख्य लेखक: | |
|---|---|
| स्वरूप: | लेख |
| भाषा: | English |
| प्रकाशित: |
Elsevier
2017-03-01
|
| श्रृंखला: | Osteoporosis and Sarcopenia |
| विषय: | |
| ऑनलाइन पहुंच: | http://www.sciencedirect.com/science/article/pii/S2405525517300043 |